PML/RARA (15;17)-AML-M3

Description:

The M3 subtype of acute myelogenous leukemia (AML) is Acute promyelocytic leukemia (APL). It is the cancer of white blood cells. The retinoic acid receptor-alpha (RARA) gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17) to give rise to AML-M3. The fusion protein interacts with the sites on the cell’s DNA which blocks transcription and differentiation of granulocytes. Thus, the PML/RARA t(15;17) test is useful for diagnosis and predicting treatment response.

Technique:

Flourescent in Situ Hybridization

Specialities:

Oncology, Clinical hematology, Medicine

Indications:

Hematological Maligancy

TAT:

3 days

Specimen Requirements:

Bone Marrow/Peripheral Blood in green top (Na-Heparin tube) 3-4 ml

Test Code:

2214

Quick Links

Maternal / Prenatal Screening

Pre-eclampsia Screening and Diagnosis

Prenatal Diagnosis

Non Invasive Prenatal Screening (NIPS)